3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Polycystic Ovary Syndrome
149
Breast Neoplasms
38
Prostatic Neoplasms
31
Insulin Resistance
30
Obesity
23
Endometrial Neoplasms
15
Neoplasms
14
Infertility
14
Colorectal Neoplasms
13
Pancreatic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Anovulation
10
Lung Neoplasms
9
Neoplasm Metastasis
8
Hyperandrogenism
8
Glioblastoma
8
Diabetes Mellitus
8
Squamous Cell Carcinoma of Head and Neck
7
Metabolic Syndrome
7
Melanoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Head and Neck Neoplasms
5
Brain Neoplasms
5
Adenocarcinoma
5
Weight Loss
4
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Interventions
Cyclophosphamide
76
fludarabine phosphate
41
Filgrastim
38
Peripheral Blood Stem Cell Transplantation
34
Radiotherapy
33
Cyclosporine
32
Busulfan
31
Etoposide
30
Mycophenolic Acid
29
Antilymphocyte Serum
28
Whole-Body Irradiation
25
Methotrexate
25
Rituximab
22
Melphalan
21
Methylprednisolone
20
Vincristine
17
Tacrolimus
16
Doxorubicin
16
Cytarabine
16
Cord Blood Stem Cell Transplantation
16
Prednisone
15
Thiotepa
10
Granulocyte Colony-Stimulating Factor
9
Carboplatin
8
Leucovorin
7
fludarabine
6
aldesleukin
6
Ifosfamide
6
sargramostim
5
Sirolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Dendritic Cell Sarcoma, Interdigitating
×
Metformin
×
Clear all
NCT02531308
2022-09-28
DLBCL
Rush University Medical Center
Phase 2
Terminated
5 enrolled
5 charts